Brinda Balakrishnan/LinkedIn
Dec 22, 2025, 12:39
Shining a Light on von Willebrand Disease: An Often Overlooked Bleeding Disorder
Brinda Balakrishnan, Board Member of Aurinia Pharmaceuticals Inc., shared a post by Star Therapeutics on LinkedIn:
“There continue to be many sizable, rare disorders with few to no therapeutic options. Glad that Star is shining a light on VWD and developing novel medicines to address patient needs!”
Quoting Star Therapeutics‘ post:
“von Willebrand Disease is often overlooked compared to other bleeding disorders like hemophilia, leaving many patients without the resources and support they deserve.
Listen as Nick shares his experience growing up with a condition that was frequently misunderstood and the impact that has had on his journey with VWD.”
Find more related posts on Hemostasis Today.
-
May 7, 2026, 17:56The Latest Clinical Data Shaping The Evolving Landscape of Hemophilia Treatment – EAHAD
-
May 7, 2026, 17:31Talha Badar: New Classical Hematology Chapter on Bleeding and Thrombosis
-
May 7, 2026, 17:26Maria Τektonidou: Gene Network Analysis Identifies STAT1 in Thrombotic APS
-
May 7, 2026, 17:23Sonu Bhaskar: Inflammatory Biomarkers in Acute Cerebral Venous Sinus Thrombosis
-
May 7, 2026, 16:53Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
-
May 7, 2026, 16:34Arun V J: Give Blood and Be the Hero You Always Wanted to Be
-
May 7, 2026, 16:15August Bones: When Would You Consider Placing an Inferior Vena Cava Filter After a Pulmonary Embolism?
-
May 7, 2026, 15:58Stop Asking Doctors to Do More – Reimagining the Care Team – The US Oncology
-
May 7, 2026, 15:42Chokri Ben Lamine: CVC-Associated UE-DVT and Catheter Removal